SCHEMBL17025280

SCHEMBL17025280

COc1ccc(Cn2cc3nc(Cl)nc(OC)c3n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.43
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 1/20 0.40
DCTPP1 Q9H773 2/20 0.40
ADORA3 P0DMS8 3/20 0.39
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
ADORA2B P29275 1/20 0.39
AADAT Q8N5Z0 1/20 0.38
THRB P10828 2/20 0.38
MAT2A P31153 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
CCNE2 O96020 1/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4103108 0.88 TP53 (0.44) TP53MEN1KMT2ANPC1RAB9A
SCHEMBL4096867 0.86 CNR1 (0.47) TP53ADORA3ADORA2AADORA1ALDH1A1
SCHEMBL14320731 0.77 ADORA3 (0.49) TP53MEN1KMT2ANPC1RAB9A
SCHEMBL22118820 0.77 LRRK2 (0.34)
SCHEMBL15650339 0.77 TP53 (0.40) TP53MEN1KMT2ANPC1RAB9A
SCHEMBL15650655 0.76 HSP90AA1 (0.44) TP53MEN1KMT2ANPC1RAB9A
SCHEMBL28722528 0.76 ADORA3 (0.56) TP53MEN1KMT2APOLBADORA3
SCHEMBL15651324 0.76 TP53 (0.41) TP53MEN1KMT2ANPC1RAB9A
SCHEMBL15651012 0.76 TP53 (0.43) TP53MEN1KMT2ANPC1RAB9A
SCHEMBL15650337 0.76 TP53 (0.39) TP53MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239889-A1 PYRAZOLOPYRIMIDINE COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239889-A1 PYRAZOLOPYRIMIDINE COMPOUND HIF1AN, EGLN2, EGLN3 TP53 2442/4885MEN1 4324/4885KMT2A 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.